Proteomics Market Growth, Size, Share, Forecast by 2030

Proteomics Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service (Instrumentation Technologies, Reagents & Consumables, and Software & Services), Application (Clinical Diagnostics, Drug Discovery & Development, and Others), End User (Pharmaceutical & Biotechnology Companies, Research & Clinical Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa) 

Publication Month : Mar 2024

  • Report Code : TIPHE100001115
  • Category : Biotechnology
  • Status : Data Released
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

[Research Report] The proteomics market size is projected to surge from US$ 27.07 billion in 2022 to US$ 75.03 billion by 2030; the market is estimated to record a CAGR of 13.6% during 2022–2030.

Analyst Perspective:

The report includes growth prospects owing to the current proteomics market trends and their foreseeable impact during the forecast period. Proteomics is the study of proteomes on a large scale. A set of proteins formed by a biological entity is known as a proteome. A proteome is not constant; it differs from cell to cell and changes over time. A proteome partially reflects the underlying transcriptome, which can also be defined as an organism's full range of messenger RNA molecules. Numerous factors influence protein activity in addition to the level of expression of a particular gene. Proteomics has numerous applications. Thus, the proteomics market is expected to grow considerably due to the increased demand for personalized medicines and increased research and development in proteomics. However, the strict regulatory requirements and dearth of skilled professionals hamper the market growth.

Market Overview:

The large-scale study of the structure and function of proteins is known as proteomics. It encompasses the rapidly evolving field of disease proteomics, which aims to identify proteins involved in human diseases and understand how their expression, structure, and function cause disease. Key factors driving the proteomics market growth include the increasing cases of cancer and other diseases. Ongoing research in proteomics can help doctors understand how proteins react in highly dynamic environments, such as in cancer patients. This is because proteomics obtains important information in the form of biomarkers. Furthermore, proteomics has proven to show significant progress. Additionally, the science of nano proteomics is expected to positively impact the market size in the coming years.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Proteomics Market: Strategic Insights

proteomics-market
Market Size Value inUS$ 27.07 billion in 2022
Market Size Value byUS$ 75.03 billion by 2030
Growth rateCAGR of 13.6% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Driver:

Increasing Cases of Chronic Diseases Propels Market Growth

The growing number of cases of chronic diseases such as cancer, respiratory diseases, chronic kidney disease (CKD), cardiovascular diseases (CVDs), and others is another factor expected to drive market growth. For example, according to Globocan, in December 2020, there were ~19.3 million new-found cancer cases worldwide, and 10 million cancer-related deaths were reported. Cardiovascular diseases are also one of the most common causes of death worldwide. For example, the WHO (2021) states that target diseases kill 41 million patients annually. Due to the increasing cases of life-threatening diseases, there is a growing demand for personalized therapies, which positively impacts the industry.

As a large number of populations around the world suffer from cancer, the need for treatments has increased significantly. Many discoveries are also being made in the field of life sciences. The characterization of human proteins is a milestone in biomedicine. Assessing gene expression at the proteome level is also important. Continuous research and development in this field will lead to significant growth in the proteomics market. This technique could provide extremely important biological information that will help understand the biology of cancer patients. Such growing cases of chronic diseases bolster the demand for proteomics.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

The proteomics market analysis has been carried out by considering the following segments: product & service, application, and end user.

Based on product & service, the proteomics market is segmented into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment held the largest market share in 2022 and is estimated to register the highest CAGR of 14.1% during 2022–2030. During the forecast period, this value is likely to increase because of the growing use of reagents & kits, consumables, and strips for studying various biological materials in research universities, research institutions, and other areas. Increasing government initiatives to support the field of proteomics and genomics, as well as increasing research activities in disease diagnostics, will also drive the proteomics market growth. Additionally, technical advancements in advanced instruments, such as 3D electrophoresis protein analyzers, which increase biological research's speed, efficiency, and productivity, which will subsequently promote market expansion.

The market, based on application, is divided into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest proteomics market share in 2022 due to researchers and clinicians' widespread use of protein analysis to identify disease biomarkers for early detection of risk factors. Also, it is possible to discover potential protein transcription regulation that can be used to identify and predict malignancies and evaluate their prognosis using proteomics-based diagnosis.

Based on end user, the proteomics market is divided into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, and others. The pharmaceutical & biotechnology companies segment held the largest proteomics market share in 2022. However, the research & clinical laboratories segment is anticipated to register the highest CAGR of 14.5% during 2022–2030. Increasing R&D funding from pharmaceutical and biotechnology companies to develop novel drugs is expected to boost the demand for proteomics services. Additionally, the need for enzymes, reagents, and kits is fueled by increased research and development activities, several ongoing proteomics studies to treat various life-threatening diseases, and increased life science projects in research and academic settings.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis:

The scope of the proteomics market report includes North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The market in North America was valued at US$ 11.95 billion in 2022 and is projected to reach US$ 33.56 billion by 2030; it is expected to register a CAGR of 13.8% during 2022–2030. One of the key factors driving the market growth in this region is the increasing investments for the development of structure-based drug design, demand for high-quality research tools for data reproducibility, growth in omics research, etc. Attention is being paid to the development of tailor-made treatments. The partnerships and collaborations between major regional companies also contribute to this market expansion. For example, Thermo Fisher Scientific Inc. and Symphogen have collaborated to develop verified platform processes for optimized characterization and quality monitoring of complex therapeutic proteins. Several protein therapies are being tested in clinical trials to treat cancer, infections, immunological disorders, age-related diseases, and other problems. Additionally, proteomics research is at its peak in countries such as the US owing to the high incidence of inherited diseases such as Alzheimer's, as well as infectious diseases such as malaria and tuberculosis, in the region.

The Asia Pacific proteomics market is expected to record the fastest CAGR of 14.3%. The region, especially with countries such as India and China, is home to a sizable pharmaceutical industry. China is a pharmaceutical manufacturing hub. The projected market growth in this region is attributed to the availability of highly functional manufacturing units and contract manufacturing facilities in the region. Further, a huge population base susceptible to cancer and other infectious diseases, extensive use of proteomics in diagnosing genetic disorders, and increasing R&D spending and social programs are expected to propel the need for proteome-based disease diagnosis, thereby boosting the market growth.

Key Player Analysis:

Proteome Sciences; Biognosys; Creative Proteomics; Shantani; Olink; SomaLogic Operating Co., Inc.; QUANTUM-SI INCORPORATED; Proteomics International; Promise Proteomics; SCIEX; Illumina, Inc.; and Thermo Fisher Scientific Inc are among the key players profiled in the proteomics market report.

Recent Developments:

Companies operating in the proteomics market adopt mergers and acquisitions as key growth strategies. As per company press releases, a few recent market developments are listed below:

  • In June 2022, SomaLogic and Illumina, Inc. announced a joint development agreement in which companies will utilize the SomaScan Proteomics Assay on Illumina's current and future high-throughput next-generation sequencing (NGS) platforms. The partnership accelerated next-generation sequencing in the proteomics market's fast-growing, ultra-high throughput workflow.
  • In May 2022, Proteomics International Laboratories Ltd received US$ 13,516 in funding to enable the production of its PromarkerD clinical diagnostic in Australia, the world's first diagnostic, predictive test for diabetes-related kidney disease. The program aims to foster new health innovations, advance discoveries toward proof-of-concept and commercialization that address important health problems and maximize entrepreneurial and idea potential.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product & Service, Application, End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the growth estimates for the proteomics market till 2030?

The proteomics market is expected to be valued at US$ 75.03 billion in 2030.

Which segment is dominating the proteomics market?

The global proteomics market, based on product & service is segmented into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment held a larger proteomics market share in 2022, and the same is predicted to register a higher CAGR of 14.1% during 2022–2030. Based on application, market is segmented into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest proteomics market share in 2022. However, the drug discovery & development segment is estimated to register the highest CAGR of 14.4% during 2022–2030. Based on end user, the market is segmented into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, others. The pharmaceutical & biotechnology companies segment held the largest proteomics market share in 2022. However, the research & clinical laboratories segment is estimated to register the highest CAGR of 14.5% during 2022–2030.

What was the estimated proteomics market size in 2022?

The proteomics market was valued at US$ 27.07 billion in 2022.

What is proteomics?

Proteomics, the detailed analysis of proteins, has become a significant field to study drug development, therapy, prognosis, and disease characterization. Proteomics technologies help with both infectious and noninfectious disease detection and therapy. The current proteomic methodologies are being made more reliable, biocompatible, specific, and reproducible through the use of nanotechnology as a technological platform. The shortcomings of conventional proteomic techniques are greatly assessed with the use of nanomaterials to enhance the quality of proteomic techniques by protein manipulation.

What are the driving factors for the proteomics market?

The factors driving the growth of the proteomics market include the proliferating cases of chronic diseases and growing prominence of nano proteomics.

Who are the major players in the proteomics market?

The proteomics market majorly consists of the players such as Proteome Sciences, Biognosys, Creative Proteomics, Shantani, Olink, SomaLogic Operating Co., Inc.; QUANTUM-SI INCORPORATED, Proteomics International, Promise Proteomics, SCIEX, Illumina, Inc.; and Thermo Fisher Scientific Inc.

The List of Companies - Proteomics Market

  1. Proteome Sciences
  2. Biognosys
  3. Creative Proteomics
  4. Shantani
  5. Olink
  6. SomaLogic Operating Co., Inc.
  7. QUANTUM-SI INCORPORATED
  8. Proteomics International
  9. Promise Proteomics
  10. SCIEX
  11. Illumina, Inc.
  12. Thermo Fisher Scientific Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Proteomics Market